PTGX and JNJ Related Headlines
Go Back- Protagonist Therapeutics (PTGX) PT Raised to $137 at Citizens
- Protagonist Therapeutics (PTGX) Said to Be Mentioned Cautiously Regarding M&A
- Protagonist Therapeutics (PTGX) PT Raised to $112 at BMO Capital
- Protagonist Therapeutics stock surges after J&J acquisition talks report
- Protagonist Therapeutics (PTGX) halted on volatility
- Johnson & Johnson (JNJ) in talks to buy Protagonist Therapeutics (PTGX) - WSJ
